ConductScience.org, home

Paper39348473

Research Progress of γδT Cells in Tumor Immunotherapy.

Li Y and 3 others. Cancer Control, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Research Progress of γδT Cells in Tumor Immunotherapy. Papers, record 39348473. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39348473

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Research Progress of γδT Cells in Tumor Immunotherapy.
PubMed
Journal
Cancer Control
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.28, provisional
iCite
Revised in PubMed
2024-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li YYanhttps://orcid.org/0009-0000-4811-1816
2Mo XPXin-Pei
3Yao HHong
4Xiong QXQiu-Xia

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
ImmunotherapyMajor topic
Humans
Intraepithelial Lymphocytes
Receptors, Antigen, T-Cell, gamma-delta

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121647691Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma.Cancer Immunol Immunother2011https://conductscience.org/library/papers/21647691PubMed
230736852Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma.J Immunother Cancer2019https://conductscience.org/library/papers/30736852PubMed
333013819Immune Effects of γδ T Cells in Colorectal Cancer: A Review.Front Immunol2020https://conductscience.org/library/papers/33013819PubMed
415287953Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.Br J Haematol2004https://conductscience.org/library/papers/15287953PubMed
531919129Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.Science2020https://conductscience.org/library/papers/31919129PubMed
630050536New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity.Front Immunol2018https://conductscience.org/library/papers/30050536PubMed
738236249Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment.Cancer Immunol Immunother2024https://conductscience.org/library/papers/38236249PubMed
837063836A close look at current γδ T-cell immunotherapy.Front Immunol2023https://conductscience.org/library/papers/37063836PubMed
929740448Working in "NK Mode": Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells.Front Immunol2018https://conductscience.org/library/papers/29740448PubMed
1016850345Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study.Cancer Immunol Immunother2007https://conductscience.org/library/papers/16850345PubMed
1118301889Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma.Cancer Immunol Immunother2008https://conductscience.org/library/papers/18301889PubMed
1235295709Folate Receptor-Alpha Targeted 7x19 CAR-γδT Suppressed Triple-Negative Breast Cancer Xenograft Model in Mice.J Oncol2022https://conductscience.org/library/papers/35295709PubMed
1324528541Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells.J Transl Med2014https://conductscience.org/library/papers/24528541PubMed
1422306909Tumor-promoting versus tumor-antagonizing roles of γδ T cells in cancer immunotherapy: results from a prospective phase I/II trial.J Immunother2012https://conductscience.org/library/papers/22306909PubMed
1535784326Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.Front Immunol2022https://conductscience.org/library/papers/35784326PubMed
1629296543IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population.Oncoimmunology2017https://conductscience.org/library/papers/29296543PubMed
1732714329Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia.Front Immunol2020https://conductscience.org/library/papers/32714329PubMed
1827667711Regulation of NKG2D Expression and Signaling by Endocytosis.Trends Immunol2016https://conductscience.org/library/papers/27667711PubMed
1929163482Current Advances in γδ T Cell-Based Tumor Immunotherapy.Front Immunol2017https://conductscience.org/library/papers/29163482PubMed
2032939032Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer.Cell Mol Immunol2021https://conductscience.org/library/papers/32939032PubMed

See all 77 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42220528Editorial: Role of gamma delta T cells in cancer immunotherapy.Front Immunol2026https://conductscience.org/library/papers/42220528PubMed
40136407Potential Benefits of Adding Alendronate, Celecoxib, Itraconazole, Ramelteon, and Simvastatin to Endometrial Cancer Treatment: The EC5 Regimen.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40136407PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39348473

GET https://conductscience.org/api/papers/v1/39348473/references?page=2